healthcare

Technology must cut administrative burden

The rhetoric over the US-China trade war has again increased, triggering the biggest fall in US stock prices since January.

Which medical companies have made the cut?

Full-year results

New addition to HAN-GINS suite

Analysts remain cautiously optimistic

When it comes to finding growth in the UK, we are positive on the pharmaceuticals sector.

Gender diversity and plastics dominate landscape

Evolving sector with artificial intelligence

What should investors look out for?